Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • REVIEWS
  • MENUS
  • RESOURCES
    • Side effect handouts
    • Patient handouts: Main page
    • How to find treatment resources
    • Rating scales and questionnaires for mental health clinicians
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • LOG IN
  • JOIN

Joseph F. Goldberg, MD: Editorial board member, Contributing author, Interviewee

Dr. Goldberg is an internationally recognized authority on bipolar disorders, psychopharmacology, and the side effects of psychiatric medications.

He is a clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City. He also maintains a private practice in Norwalk, CT. The website for his private practice is www.josephgoldbergmd.com.

He has published over 180 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, including the excellent “Managing the Side Effects of Psychotropic Medications,” the second edition of which was published in 2018 by American Psychiatric Publishing. For our review of this book, please see the following page on this website: BEST Books about managing side effects (adverse effects) of psychotropic medications

Dr. Goldberg completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York-Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He was previously Director of the Affective Disorders Research Program at Silver Hill Hospital in New Canaan, CT.

Dr Goldberg was the President (2023 to 2025) of the American Society of Clinical Psychopharmacology, and is on the editorial boards for a number of peer-reviewed journals.

His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention.


Disclosures

​(updated May 2025)

Consultant/Advisor: Alkermes, Inc.; Genomind; Luye Pharmaceuticals; Neurelis; Neumora Therapeutics Inc; Otsuka Pharmaceutical Co., Ltd.; Sunovion; Supernus Pharmaceuticals, Inc.

​​Speakers Bureau: AbbVie Inc.; Alkermes, Inc.; Axsome Therapeutics, Inc.; Bristol Myers Squibb Company; Intra-Cellular Therapies


Copyright © 2021 to 2025, Simple and Practical Medical Education, LLC.  All rights reserved. May not be reproduced in any form without express written permission.

Share this:

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email

Leave a Reply:Cancel reply

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter

Copyright 2016 to 2025: Simple and Practical Medical Education, LLC. All rights reserved.

 

Loading Comments...